MyFinsight
Home
Blog
About
Accounts receivable, net
-$572,932
(-378.91%↓ Y/Y)
Stock based
compensation
$339,970
(5628.22%↑ Y/Y)
Accretion and
amortization expenses
-$196,636
(-28.04%↓ Y/Y)
Operating right of use
assets amortization
$126,302
Deposits and other
receivables
-$122,675
(-349.76%↓ Y/Y)
Change in fair value of
derivative liabilities
-$110,051
(-336.71%↓ Y/Y)
Accounts payable and
accrued liabilities
$80,348
(-83.69%↓ Y/Y)
Property, plant and
equipment depreciation
$1,488
Net cash generated
(used) in operating...
$507,227
(235.84%↑ Y/Y)
Canceled cashflow
$1,043,175
Net increase
(decrease) in cash during...
$316,292
(407.56%↑ Y/Y)
Canceled cashflow
$190,935
Net loss
-$959,468
(-42.78%↓ Y/Y)
Inventory
$83,707
(-63.29%↓ Y/Y)
Net cash provided
(used) in financing...
-$190,935
(-143.82%↓ Y/Y)
Proceeds from (repayment
to) short term loan...
-$184,935
(-141.88%↓ Y/Y)
Preferred stock dividend
$6,000
(1.39%↑ Y/Y)
Back
Back
Cash Flow
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)
source: myfinsight.com